CYP2J2*7 single nucleotide polymorphism in a Chinese population

Clinica Chimica Acta

Volumn 365, Issue 1-2, 2006, Pages 125-128

  Wang, Haijian ^a,b   Jiang, Yan ^a   Liu, Yang ^a   Lin, Chengzhao ^a   Cheng, Gang ^a   Chen, Xiaoping ^c   Hao, Bingtao ^c   Tan, Wen ^d   Lin, Dongxin ^a,d   He, Fuchu ^a,c  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^d CANCER HOSPITAL   (China)

Author keywords

Chinese; CYP2J2; Cytochrome P450; Genetic polymorphism

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 2J2; UNCLASSIFIED DRUG; ARACHIDONATE EPOXYGENASE; OXYGENASE; PRIMER DNA;

ADULT; AGED; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MALE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; CHINA; GENETICS; NUCLEOTIDE SEQUENCE; PROMOTER REGION;

ALLELES; BASE SEQUENCE; CHINA; CYTOCHROME P-450 ENZYME SYSTEM; DNA PRIMERS; GENE FREQUENCY; HUMANS; OXYGENASES; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS);

EID: 32044443160     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2005.08.007     Document Type: Article

References (18)

1. S. Wu, C.R. Moomaw, K.B. Tomer, J.R. Falck, and D.C. Zeldin Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart J Biol Chem 271 1996 3460 3468
2. J.H. Capdevila, J.R. Falck, and R.C. Harris Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase J Lipid Res 41 2000 163 181
3. J. Seubert, B. Yang, and J.A. Bradbury Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway Circ Res 95 2004 506 514
4. Y. Wang, X. Wei, and X. Xiao Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways J Pharmacol Exp Ther 314 2005 522 532
5. M. Spiecker, H. Darius, and T. Hankeln Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2 Circulation 110 2004 2132 2136
6. L.M. King, J.V. Gainer, and G.L. David Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension Pharmacogenet Genomics 15 2005 7 13
7. J.G. Jiang, C.L. Chen, and J.W. Card Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors Cancer Res 65 2005 4707 4715
8. T. Hashizume, S. Imaoka, and M. Mise Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes J Pharmacol Exp Ther 300 2002 298 304
9. S. Matsumoto, T. Hirama, T. Matsubara, K. Nagata, and Y. Yamazoe Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizole Drug Metab Dispos 30 2002 1240 1245
10. L.M. King, J. Ma, and S. Srettabunjong Cloning of CYP2J2 gene and identification of functional polymorphisms Mol Pharmacol 61 2002 840 852
11. S.S. Lee, H.E. Jeong, and K.H. Liu Identification and functional characterization of novel CYP2J2 variants: G312R variant causes loss of enzyme catalytic activity Pharmacogenet Genomics 15 2005 105 113
12. H. Wang, W. Tan, and B. Hao Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK Cancer Res 63 2003 8057 8061
13. E.G. Burchard, E. Ziv, and N. Coyle The importance of race and ethnic background in biomedical research and clinical practice N Engl J Med 348 2003 1170 1175
14. J.L. Mountain, and N. Risch Assessing genetic contributions to phenotypic differences among 'racial' and 'ethnic' groups Nat Genet 36 2004 S48 S53
15. M.J. Glover, K.J. Greenlund, C. Ayala, and J.B. Croft Racial/ethnic disparities in prevalence, treatment, and control of hypertension-United States, 1999-2002 JAMA 293 2005 923 925
16. D. Gu, K. Reynolds, and X. Wu Prevalence, awareness, treatment, and control of hypertension in China Hypertension 40 2002 920 927
17. National center for health statistics Health, United States, 2004. With chartbook on trends in the health of Americans 2004 U.S. Government Printing Office Washington, DC 20402 Hyattsville, Maryland
18. D. Zhu, M. Bousamra 2nd, and D.C. Zeldin Epoxyeicosatrienoic acids constrict isolated pressurized rabbit pulmonary arteries Am J Physiol Lung Cell Mol Physiol 278 2000 L335 L343